Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Degeneracy, as opposed to specificity, in immunotherapy.

Degeneracy, as opposed to specificity, in immunotherapy. J Clin Invest. 2002 Mar; 109(5):581-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.